contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-presentation-of-the-cellavision-report-for-the-third-quarter-2022-on-october-26-at-1100-cest

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company focuses on digital cell morphology and offers innovations for analyzers, instruments, reagents and software used in hematology laboratories. The company's products are aimed at healthcare institutions and laboratories worldwide. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.

CellaVision

CellaVision AB (publ) will publish the Interim report for the third quarter, on October 26, 2022 at 7:20 CEST. The report will be available at ir.cellavision.comIn connection with the release...

<div class="mfn-preamble"><p><strong>CellaVision AB (publ) will publish the Interim report for the third quarter, on October 26, 2022 at 7:20 CEST. The report will be available at ir.cellavision.com</strong></p></div><div class="mfn-body"><p>In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CEST where Simon Østergaard, President &amp; CEO, will present and comment the report.</p><p>The presentation will be in English via a conference call or audio webcast:<br><a rel="nofollow noopener" href="https://ir.financialhearings.com/cellavision-q3-2022">https://ir.financialhearings.com/cellavision-q3-2022</a></p><p><strong>Dial in details: </strong><strong><br></strong>SE: +46 8 51 9993 83</p><p>UK: +44 33 33 009 268</p><p>US: +1 64 67 224&nbsp;902</p><p>No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time to facilitate a timely start.</p></div><div class="mfn-footer mfn-c88db445e695"><p><strong class="mfn-heading-1">Contact</strong></p><hr><p>Adele Horn<br>Corporate Communications &amp; Investor Relations<br>Direct: + 46 46&nbsp;460 26 04<br>Mobile: + 46 72&nbsp;206 50 88<br><a rel="nofollow noopener" href="http://www.cellavision.com/">www.cellavision.com</a><br><a rel="nofollow noopener" href="mailto:adele.horn@cellavision.com">adele.horn@cellavision.com</a></p></div><div class="mfn-footer mfn-about mfn-e1c44dcaa8c5"><p><strong class="mfn-heading-1">About Us</strong></p><hr><p>CellaVision is a global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in sample preparation, image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the parent company in Lund and by the company´s 17 local market support organizations covering more than 40 countries. In 2021, sales were SEK 566 million and the company's growth target is 15% per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="nofollow noopener" class="mfn-generated mfn-primary" href="https://storage.mfn.se/7fd2c5bf-6cbb-489f-a92b-93d68772ac16/invitation-to-presentation-of-the-cellavision-report-for-the-third-quarter-2022-on-october-26-at-11-00-cest.pdf">Invitation to presentation of the CellaVision report for the third quarter 2022 on October 26, at 11:00 CEST</a></p></div>

Invitation to presentation of the CellaVision report for the third quarter 2022 on October 26, at 11:00 CEST